Study to Evaluate the Use of Surgical Gloves for the Prevention of Oxaliplatin-Induced Peripheral Neuropathy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAC Camargo Cancer Center
About this trial
The primary objective of this randomized clinical trial is to assess whether the use of surgical gloves during treatment can prevent the occurrence of oxaliplatin-induced peripheral neuropathy.
Eligibility criteria
Qualifiers
Patients aged 18 years or older who have provided written informed consent.
Colon adenocarcinoma with high-risk stage III (pT4pN2) or stage IV.
Oxaliplatin-based treatment in the context of localized or metastatic disease.
Eastern Cooperative Oncology Group (ECOG) performance status of 0-1.
Disqualifiers
Pre-existing neuropathy.
Uncontrolled diabetes.
known glove allergies.
Prior treatment with paclitaxel, docetaxel or oxaliplatin.
Trial design
Treatments tested in this trial
- Surgical Gloves
Treatment groups
84 Participants
are divided into 2 treatment groupsSponsors and collaborators
AC Camargo Cancer Center
Lead sponsor
Hospital do Cancer de Londrina
Collaborator
Source ClinicalTrials.gov